Novo Nordisk eyes further European manufacturing expansion as it buys land in Ireland

No­vo Nordisk is look­ing at boost­ing its man­u­fac­tur­ing foot­print in Eu­rope, with Ire­land as one of the coun­tries the phar­ma gi­ant is con­sid­er­ing, a spokesper­son told End­points News.

An 85-acre (343,983 square-me­ter) plot of land near Dublin has been ear­marked as a po­ten­tial pro­duc­tion hub for its meta­bol­ic dis­ease as­sets. “We have ac­quired land at Grange Cas­tle Busi­ness Park and have sub­mit­ted a plan­ning ap­pli­ca­tion,” the spokesper­son added in an email.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.